Evidence map›Paper›PMID 26647385›Full record

ArticleDiabetes2016

Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.

Marc A Soares, Oriana D Cohen, Yee Cheng Low, Rita A Sartor, Trevor Ellison, Utkarsh Anil, Lavinia Anzai, Jessica B Chang, Pierre B Saadeh, Piul S Rabbani and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Diabetic neuropathy: A NRF2 disease?Journal of diabetes · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Monitoring Nrf2/ARE Pathway Activity with a New Zebrafish Reporter System.International journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Marc A SoaresHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Oriana D CohenHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Yee Cheng LowHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Rita A SartorHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Trevor EllisonHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Utkarsh AnilHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Lavinia AnzaiHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Jessica B ChangHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Pierre B SaadehHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Piul S RabbaniHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY.
Daniel J CeradiniHansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY daniel.ceradini@nyumc.org.
NYU Langone Health · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2012 to 2014
$16.8M
Training Program in Stem Cell and Cancer BiologyT32CA160002 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEHMANN, RUTH · 2011 to 2015
$1.6M
NCATS NIH HHS UL1 TR000038NCATS NIH HHS UL1 TR00038NCI NIH HHS P30 CA016087NCI NIH HHS P30CA016087NCI NIH HHS T32 CA160002NCI NIH HHS T32CA160002
6 · The paper itself

Abstract

Chronic hyperglycemia impairs intracellular redox homeostasis and contributes to impaired diabetic tissue regeneration. The Keap1/Nrf2 pathway is a critical regulator of the endogenous antioxidant response system, and its dysfunction has been implicated in numerous pathologies. Here we characterize the effect of chronic hyperglycemia on Nrf2 signaling within a diabetic cutaneous regeneration model. We characterized the effects of chronic hyperglycemia on the Keap1/Nrf2 pathway within models of diabetic cutaneous wound regeneration. We assessed reactive oxygen species (ROS) production and antioxidant gene expression following alterations in the Nrf2 suppressor Keap1 and the subsequent changes in Nrf2 signaling. We also developed a topical small interfering RNA (siRNA)-based therapy to restore redox homeostasis within diabetic wounds. Western blotting demonstrated that chronic hyperglycemia-associated oxidative stress inhibits nuclear translocation of Nrf2 and impairs activation of antioxidant genes, thus contributing to ROS accumulation. Keap1 inhibition increased Nrf2 nuclear translocation, increased antioxidant gene expression, and reduced ROS production to normoglycemic levels, both in vitro and in vivo. Topical siKeap1 therapy resulted in improved regenerative capacity of diabetic wounds and accelerated closure. We report that chronic hyperglycemia weakens the endogenous antioxidant response, and the consequences of this defect are manifested by intracellular redox dysregulation, which can be restored by Keap1 inhibition. Targeted siRNA-based therapy represents a novel, efficacious strategy to reestablish redox homeostasis and accelerate diabetic cutaneous tissue regeneration.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBlotting, WesternCytoskeletal ProteinsDiabetes MellitusFluorescent Antibody TechniqueGlutathioneHyperglycemiaImmunoprecipitationKelch-Like ECH-Associated Protein 1MiceMice, Inbred C57BLMice, Inbred StrainsNF-E2-Related Factor 2NIH 3T3 CellsOxidative StressAdaptor Proteins, Signal TransducingCytoskeletal ProteinsGlutathioneKeap1 protein, mouseKelch-Like ECH-Associated Protein 1Nfe2l2 protein, mouseNF-E2-Related Factor 2Reactive Oxygen Species

Identifiers

PMID26647385
PMCPMC5314719
OpenAlexW2275709613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.